Drug Type Small molecule drug |
Synonyms Poperidine carboxamine azaindane derivative 3A |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC28H22F6N4O3S |
InChIKeyQXPIWISEYYAEFF-YZNIXWLBSA-N |
CAS Registry3003751-32-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Migraine Disorders | Discovery | CN | 27 Apr 2023 |